Granted Patent
B1
US 12,404,547 · App. 18/936,839 · Granted Sep 2, 2025
Methods and systems for monitoring a recipient of an allograft
Inventors:
Robert Woodward (Pleasanton, CA); Marica Grskovic (Burlingame, CA); James Yee (San Mateo, CA); Mitch Nelles (Half Moon Bay, CA); David Hiller (Brisbane, CA)
View Patent ↗
Loading inventors, assignments & file history…
Abstract
A method for sequencing can be used to monitor a recipient of an allograft. A sample comprising nucleic acid molecules can be provided from the recipient of the allograft. A plurality of nucleic acid molecules can be isolated from the sample and amplified. The plurality of nucleic acid molecules can be subjected to one or more amplification reactions using a plurality of primers to generate a plurality of DNA molecules. The plurality of primers can target at least 100 independent polymorphisms. The DNA molecules, or derivatives thereof, can be sequenced. The method may not require genotyping of the recipient.
Claims (28)
1. A method for sequencing, comprising:
(a) providing a sample of a subject, wherein said sample comprises a plurality of cell-free nucleic acid molecules, and wherein said subject is a recipient of an allograft;
(b) isolating said plurality of cell-free nucleic acid molecules from said sample;
(c) amplifying said plurality of cell-free nucleic acid molecules to generate a plurality of amplified nucleic acid molecules;
(d) subjecting said plurality of amplified nucleic acid molecules, or derivatives thereof, to one or more amplification reactions using a plurality of primers to generate a plurality of deoxyribonucleic acid (“DNA”) molecules, wherein said plurality of primers target at least 100 independent polymorphisms; and
(e) sequencing said plurality of DNA molecules, or derivatives thereof,
wherein genotyping of said subject is not performed.
2. The method of claim 1 , wherein said one or more amplification reactions comprises polymerase chain reaction (PCR).
3. The method of claim 1 , further comprising purifying said plurality of DNA molecules, or derivatives thereof.
4. The method of claim 1 , wherein said sequencing in (e) comprises detecting an optical signal from a probe coupled to a DNA molecule or a derivative thereof of said plurality of DNA molecules or derivatives thereof.
5. The method of claim 1 , wherein said sample is derived from blood.
6. The method of claim 1 , wherein said sample comprises peripheral blood mononuclear cells.
7. The method of claim 1 , wherein said sample is plasma.
8. The method of claim 1 , wherein said plurality of amplified nucleic acid molecules in (d) are amplified using a panel that differentiates between cell-free nucleic acid molecules of said plurality of cell-free nucleic acid molecules.
9. The method of claim 1 , further comprising barcoding said plurality of cell-free nucleic acid molecules prior to (c).
10. The method of claim 1 , wherein said allograft is a kidney, a liver, a lung, a heart, a pancreas, a cornea transplant, a skin transplant, an organ system transplant, a xenotransplant, a bone marrow transplant, a stem cell transplant, or a combination thereof.
11. The method of claim 1 , wherein two or more polymorphisms of said at least 100 independent polymorphisms comprise single nucleotide polymorphisms (SNPs).
12. The method of claim 1 , wherein two or more polymorphisms of said at least 100 independent polymorphisms are homozygous in said subject.
13. The method of claim 1 , further comprising obtaining a second sample from said subject.
14. The method of claim 13 , wherein said second sample comprises peripheral blood mononuclear cells (PBMCs).
15. The method of claim 14 , wherein said second sample comprises a plurality of nucleic acid molecules comprising ribonucleic acid (RNA) molecules isolated from said PBMCs.
16. The method of claim 1 , wherein said sequencing is next generation sequencing.
17. The method of claim 1 , wherein said allograft is obtained from a donor, and wherein genotyping of said donor is not performed.
18. The method of claim 1 , wherein said plurality of primers target at least 105 independent polymorphisms.
19. The method of claim 1 , wherein said plurality of primers target at least 110 independent polymorphisms.
20. The method of claim 1 , wherein said plurality of primers target at least 115 independent polymorphisms.
21. The method of claim 1 , wherein said plurality of primers target at least 120 independent polymorphisms.
22. The method of claim 1 , wherein said plurality of primers target at least 150 independent polymorphisms.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jul 17, 2025
From: WOODWARD, ROBERT; GRSKOVIC, MARICA; YEE, JAMES; NELLES, MITCH; HILLER, DAVID
To: CAREDX, INC.
Reel/Frame 071745/0451 →
Continuity (3)
References Cited (156)
US 6132997A
· Shannon
· 2000
[cited by applicant]
US 7655399B2
· Cantor et al.
· 2010
[cited by applicant]
US 9370689B2
· Guillama et al.
· 2016
[cited by applicant]
US 20020197621A1
· Drmanac
· 2002
[cited by applicant]
US 20020197630A1
· Knapp et al.
· 2002
[cited by applicant]
US 20040137470A1
· Dhallan
· 2004
[cited by applicant]
US 20060228721A1
· Leamon et al.
· 2006
[cited by applicant]
US 20070095905A1
· Kadaba
· 2007
[cited by applicant]
US 20070248978A1
· Lal et al.
· 2007
[cited by applicant]
US 20100151471A1
· Faham
· 2010
[cited by examiner]
US 20110173023A1
· LeClair et al.
· 2011
[cited by applicant]
US 20120295810A1
· Quake et al.
· 2012
[cited by applicant]
US 20130024127A1
· Stuelpnagel et al.
· 2013
[cited by applicant]
US 20130173028A1
· Felty et al.
· 2013
[cited by applicant]
US 20130178371A1
· Oliphant et al.
· 2013
[cited by applicant]
US 20140088995A1
· Damani
· 2014
[cited by applicant]
US 20150154352A1
· Johnson et al.
· 2015
[cited by applicant]
US 20150191787A1
· Muthukumar et al.
· 2015
[cited by applicant]
US 20150203916A1
· Ikonomidis et al.
· 2015
[cited by applicant]
US 20160115541A1
· Schutz et al.
· 2016
[cited by applicant]
US 20160369333A1
· Babiarz et al.
· 2016
[cited by applicant]
US 20170086011A1
· Neves et al.
· 2017
[cited by applicant]
US 20170335369A1
· Fields et al.
· 2017
[cited by applicant]
US 20180049675A1
· Kerber
· 2018
[cited by applicant]
US 20180344215A1
· Ohnemus et al.
· 2018
[cited by applicant]
US 20190203264A1
· Quake
· 2019
[cited by examiner]
US 20210037813A1
· Scalea et al.
· 2021
[cited by applicant]
US 20220051803A1
· Nelson
· 2022
[cited by applicant]
US 20220073989A1
· Sarwal
· 2022
[cited by examiner]
US 20220093208A1
· Lefkowitz et al.
· 2022
[cited by applicant]
US 20230287497A1
· Moshkevich
· 2023
[cited by examiner]
US 20230407392A1
· Woodward et al.
· 2023
[cited by applicant]
CN 102618626A
· 2012
[cited by applicant]
CN 103374518A
· 2013
[cited by applicant]
EP 3712898A1
· 2020
[cited by applicant]
WO WO2011057061A1
· 2011
[cited by applicant]
WO WO2012019193A2
· 2012
[cited by applicant]
WO WO2012019200A2
· 2012
[cited by applicant]
WO WO2013043922A1
· 2013
[cited by applicant]
WO WO2013049892A1
· 2013
[cited by applicant]
WO WO2013159035A2
· 2013
[cited by applicant]
WO WO2014074501A1
· 2014
[cited by applicant]
WO WO2014116729A2
· 2014
[cited by applicant]
WO WO2014194113A2
· 2014
[cited by applicant]
WO WO2015069933A1
· 2015
[cited by applicant]
WO WO2018000031A1
· 2018
[cited by applicant]
WO WO2020172164A1
· 2020
[cited by applicant]
WO WO2021021657A1
· 2021
[cited by applicant]
Access Array™ Barcode Library for Illumina Sequencers—384 (Bidirectional); Standard BioTools™. PN100-3771. 3 pages (2023).
[cited by applicant]
Access Array System for Illumina Sequencing Systems: User guide. PN 100-3770 M1. Fluidigm Corporation. 90 pages (2019).
[cited by applicant]
Agbor-Enoh Sean et al., Circulating cell-free DNA as a biomarker of tissue injury: Assessment in a cardiac xenotransplantation model. Journal of Heart and Lung Transplantation. 37(8):967-975 (2018).
[cited by applicant]
Akalin Enver et al., Clinical Validation of an Immune Quiescence Gene Expression Signature in Kidney Transplantation. Kidney360. 2(12):1998-2009 (2021).
[cited by applicant]
Bader, P. et al. How and when should we monitor chimerism after allogeneic stem cell transplantation?. Bone marrow transplantation 35(2):107-119 (2005).
[cited by applicant]
Barker, Juliet N. et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105(3):1343-1347 (2005).
[cited by applicant]
Bay, Jakob T. et al., Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidney et al., , Kidney International. 84(3):562-569 (2013).
[cited by applicant]
Beck, Julia et al., et al., Digital Droplet PCR for Rapid Quantification of Donor DNA in the Circulation of Transplant Recipients as a Potential Universal Biomarker of Graft Injury.Clinical Chemistry. 59(12):1732-1741 (…
[cited by applicant]
Beszteri, . Bánk et al., Average genome size: a potential source of bias in comparative metagenomics. The ISME Journal 4(8):1075-1077 (2010).
[cited by applicant]
Biswas, Chandra S. et al., Double Haploidentical Hematopoietic Stem Cell Transplantation Results in Successful Engraftment of Bone Marrow from Both Donors without Graft-versus-Host or Graft-versus-Graft Effects. Biol Bl…
[cited by applicant]
Bloom, Roy D. et al. Cell-free DNA and active rejection in kidney allografts. Journal of the American Society of Nephrology 28(7):2221-2232 (2017).
[cited by applicant]
Cassuto, James R. et al., Kidney transplantation in patients with a prior heart transplant et al., Transplantation 89(4): 427-433 (2010).
[cited by applicant]
Cha, Rita S. and Thilly, William G. Specificity, efficiency, and fidelity of PCR. Genome Research 3(3): S18-S29. (1993).
[cited by applicant]
Chiu, Rossa W. K., et al., Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clinical Chemistry. 47(9):1607-1613 (2001).
[cited by applicant]
Christakoudi, Sofia et al. Development of a multivariable gene-expression signature targeting T-cell-mediated rejection in peripheral blood of kidney transplant recipients validated in cross-sectional and longitudinal s…
[cited by applicant]
Chu, Tianjiao et al., A novel approach toward the challenge of accurately quantifying fetal DNA in maternal plasma. Prenatal Diagnosis. 30(12-13):1226-1229 (2010).
[cited by applicant]
Colobran, R. et al. Copy number variation in the CCL4L gene is associated with susceptibility to acute rejection in lung transplantation. Genes & Immunity 10(3):254-259 (2009).
[cited by applicant]
Crespo-Leiro, M. et al. Increased Plasma Levels of Donor-Derived Cell-Free DNA Correlate With Rejection in Heart Transplant Recipients: The Cargo II Multicenter Trial. The Journal of Heart and Lung Transplantation 34(4)…
[cited by applicant]
Davey, John W. et al. Genome-wide genetic marker discovery and genotyping using next-generation sequencing. Nature Reviews Genetics 12(7):499-510 (2011).
[cited by applicant]
DbSNP—Submitted SNP(ss) details: ss1341432998, submitted Aug. 16, 2014. 2 pages (2014). Available at: https://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.cgi?subsnp_id=ss1341432998.
[cited by applicant]
DbSNP Short Genetic Variations_Reference SNP (rs) Report; rs1047979. 12 pages, released Sep. 21, 2022. Retrieved from https://www.ncbi.nlm.nih.gov/snp/rs1047979.
[cited by applicant]
De Vlaminck, Iwijn. et al. Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Science translational medicine 6(241):241ra77, 1-8 (2014).
[cited by applicant]
Dedrick, Russell L. Understanding gene expression patterns in immune-mediated disorders. Journal of Immunotoxicology 4(3):201-207 (2007).
[cited by applicant]
Deng, M. C. et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. American Journal of Transplantation 6(1):150-160 (2006).
[cited by applicant]
Deng, Yangyang. et al. Quantification of Circulating Pig-Specific DNA in the Blood of a Xenotransplantation Model. J. Vis. Exp 163:e61579, 1-12 (2020).
[cited by applicant]
Dharnidharka, Vikas R, and Andrew Malone. Biomarkers to detect rejection after kidney transplantation. Pediatric Nephrology 33(7):1113-1122 (2018). Published online on Jun. 19, 2017.
[cited by applicant]
Egidio, Camila et al. Universal Sensitive, Accurate and Precise Microchimerism Surveillance Solution for Allogeneic Hematopoietic Cell Transplant. Blood 136:32-33 (2020).
[cited by applicant]
Feng, Kai-chao. et al. Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma. Journal of hematology & oncology 10:4, 1-11 (2017…
[cited by applicant]
Fu, Qiang. et al. An unbiased machine learning exploration reveals gene sets predictive of allograft tolerance after kidney transplantation. Frontiers in Immunology 12:695806, 1-10 (2021).
[cited by applicant]
Gadi, Vijayakrishna K. et al. Soluble donor DNA and islet injury after transplantation. Transplantation 92(5):607-611 (2011).
[cited by applicant]
Gotoh, Mitsukazu. et al. Multiple donor allotransplantation: a new approach to pancreatic islet transplantation. Transplantation 45(6):1008-1011 (1988).
[cited by applicant]
Gotoh, Takahiro et al., Prediction of MYCN amplification in neuroblastoma using serum DNA and real-time quantitative polymerase chain reaction. J Clin Oncology. 23(22):5205-5210 (2005).
[cited by applicant]
Han, Dongmei. et al. Assessment of cytotoxic lymphocyte gene expression in the peripheral blood of human islet allograft recipients: elevation precedes clinical evidence of rejection. Diabetes 53(9):2281-2290 (2004).
[cited by applicant]
Hanvesakul, Rajesh. et al. Donor HLA-C genotype has a profound impact on the clinical outcome following liver transplantation. American Journal of Transplantation 8(9):1931-1941 (2008).
[cited by applicant]
Hochberg, Ephraim P. et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood, The Journal of the American Societ…
[cited by applicant]
Hollander, Zsuzsanna. et al. Whole blood biomarkers of acute cardiac allograft rejection: double-crossing the biopsy. Transplantation 90(12):1388-1393 (2010).
[cited by applicant]
Hummert, C et al. Creation and comparison of different chip definition files for Affymetrix microarrays. International Conference on Bioinformatics and Computational Biology . BIOCOMP'11. pp. 16-22 (2011).
[cited by applicant]
Jun, Goo. et al. Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data. The American Journal of Human Genetics 91(5):839-848 (2012).
[cited by applicant]
Jun, Goo. et al. Supplemental Information: Detecting and estimating contamination of human DNA samples in sequencing and array-based genotype data. The American Journal of Human Genetics 91(5):839-848 (2012).
[cited by applicant]
Kamboj, Mini. et al. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Biology of Blood and Marrow Transplantation 16(11)…
[cited by applicant]
Kanwar, Manreet K. et al. Impact of cytomegalovirus infection on gene expression profile in heart transplant recipients. The Journal of Heart and Lung Transplantation 40(2):101-107 (2021). Published Online on Nov. 22, 2…
[cited by applicant]
Kim, Jieun. et al. SNP-based next-generation sequencing reveals low-level mixed chimerism after allogeneic hematopoietic stem cell transplantation. Annals of Hematology 97(9):1731-1734 (2018).
[cited by applicant]
Kurian, S. M. et al. Molecular classifiers for acute kidney transplant rejection in peripheral blood by whole genome gene expression profiling. American Journal of Transplantation 14(5):1164-1172 (2014).
[cited by applicant]
Li, Hong. et al. Copy number variation in CCL3L1 gene is associated with susceptibility to acute rejection in patients after liver transplantation. Clinical transplantation 26(2):314-321 (2012).
[cited by applicant]
Li, Ying. et al. Ready detection of donor-specific single-nucleotide polymorphisms in the urine of renal transplant recipients by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinical ch…
[cited by applicant]
Lichtenstein, Anatoly V. et al. Novel applications of polymerase chain reaction to urinary nucleic acid analysis. Clinical Applications of PCR 336:145-154 (2006).
[cited by applicant]
Liu, Jun. et al. Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies. Journal of hematology & oncology 10(1):35, 1-8 (2017).
[cited by applicant]
Liu, Lin et al., Comparison of next-generation sequencing systems. Journal of Biomedicine and Biotechnology. 2012:251364, pp. 1-11 (2012).
[cited by applicant]
Mao, Youying. et al. CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy. Journal of clinical immunology 31(3):414-4…
[cited by applicant]
Merani, Shaheed, and AM James Shapiro. Current status of pancreatic islet transplantation. Clinical science 110(6):611-625 (2006).
[cited by applicant]
Miotke, Laura. et al. High sensitivity detection and quantitation of DNA copy number and single nucleotide variants with single color droplet digital PCR. Analytical chemistry 86(5):2618-2624 (2014).
[cited by applicant]
Nielsen, Rasmus. et al. Genotype and SNP calling from next-generation sequencing data. Nature Reviews Genetics 12(6):443-451 (2011).
[cited by applicant]
Oeth, Paul et al., Qualitative and Quantitative Genotyping Using Single Base Primer Extension Coupled with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MassARRAY®). Single Nucleotide Pol…
[cited by applicant]
Pakstis, Andrew J. et al. SNPs for a universal individual identification panel. Human genetics 127(3):315-324 (2010).
[cited by applicant]
Pereira, Mariana Buongermino. et al. Comparison of normalization methods for the analysis of metagenomic gene abundance data. BMC genomics 19(1):274, 1-17 (2018).
[cited by applicant]
Qiagen®: QIAamp® Circulating Nucleic Acid Handbook. 64 pages, (2019).
[cited by applicant]
Quail, Michael et al., A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 13:341, pp. 1-13 (2012).
[cited by applicant]
Samper, Isabelle C. et al. Portable microfluidic biosensing system for real-time analysis of microdialysate in transplant kidneys. Analytical chemistry 91(22):14631-14638 (2019).
[cited by applicant]
Sathirapatya, Tikumphorn. et al. A SNP panel for early detection of artificial chimerism in HSCT patients using TaqMan technology. International Journal of Legal Medicine 134(5):1553-1561 (2020).
[cited by applicant]
Saukkonen, Katri et al., Cell-Free Plasma DNA as a Predictor of Outcome in Severe Sepsis and Septic Shock. Clinical Chemistry 54(6):1000-1007 (2008).
[cited by applicant]
Sigdel, Tara. et al. Assessment of 19 genes and validation of CRM gene panel for quantitative transcriptional analysis of molecular rejection and inflammation in archival kidney transplant biopsies. Frontiers in Medicin…
[cited by applicant]
Smith, Anajane G. et al. Comparison of sequence-specific oligonucleotide probe vs next generation sequencing for HLA-A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: toward single-pass high-resolution HLA t…
[cited by applicant]
Snyder, Thomas M. et al. Universal noninvasive detection of solid organ transplant rejection. Proceedings of the National Academy of Sciences 108(15):6229-6234 (2011).
[cited by applicant]
Stein, Richard A. Next-Generation Sequencing Update. vol. 28, No. 15, 7 pages (Sep. 1, 2008). Available at https://www.genengnews.com/insights/next-generation-sequencing-update/.
[cited by applicant]
Stemmer, Christine et al., Use of magnetic beads for plasma cell-free DNA extraction: toward automation of plasma DNA analysis for molecular diagnostics. Clinical Chemistry. 49(11):1953-1955 (2003).
[cited by applicant]
Suzuki, Nobuyasu et al., Characterization of circulating DNA in healthy human plasma. Clinica Chimica Acta. 387(1-2):55-58 (2008).
[cited by applicant]
Swinkels, Dorine W. et al., Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clinical Chemistry. 49(3):525-526 (2003).
[cited by applicant]
Taira, Chiaki. et al. Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR. Clinica Chim…
[cited by applicant]
Tamkovich, Svetlana N. et al., Circulating nucleic acids in blood of healthy male and female donors. Clinical Chemistry. 51(7):1317-1319 (2005).
[cited by applicant]
Toso, Christian. et al. Histologic graft assessment after clinical islet transplantation. Transplantation 88(11):1286-1293 (2009).
[cited by applicant]
Van Loon, Elisabet. et al. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: a multicentre, prospective study. EBioMedicine 46:463-472 (2019).
[cited by applicant]
Vazirabad, Ibrahim. et al. Direct HLA genetic comparisons identify highly matched unrelated donor-recipient pairs with improved transplantation outcome. Biology of Blood and Marrow Transplantation 25(5):921-931 (2019). …
[cited by applicant]
Wagner, Ines. et al. Allele-level KIR genotyping of more than a million samples: workflow, algorithm, and observations. Frontiers in immunology 9:2843, 1-15 (2018).
[cited by applicant]
Wang, H. et al. Establishment of a quantitative polymerase chain reaction assay for monitoring chimeric antigen receptor T cells in peripheral blood. Transplantation Proceedings 50(1):104-109 (2018).
[cited by applicant]
Wilm, Andreas et al., LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Research. 40(22):11189-11201 (2…
[cited by applicant]
Wong. L. The Evolution and Innovation of Donor-Derived Cell-Free DNA Testing in Transplantation. Journal of Medical Diagnostic Methods 9(5):302, 1-5 (2020).
[cited by applicant]
Zhou, Ming. et al. Circulating pig-specific DNA as a novel biomarker for monitoring xenograft rejection. Xenotransplantation 26(4):e12522, 1-12 (2019).
[cited by applicant]
Chen, Yan. et al. Peripheral blood transcriptome sequencing reveals rejection-relevant genes in long-term heart transplantation. International Journal of Cardiology 168(3):2726-2733 (2013).
[cited by applicant]
Co-pending U.S. Appl. No. 18/935,347, inventors Woodward; Robert et al., filed Nov. 1, 2024.
[cited by applicant]
Co-pending U.S. Appl. No. 18/935,348, inventors Woodward; Robert et al., filed Nov. 1, 2024.
[cited by applicant]
Co-pending U.S. Appl. No. 18/935,360, inventors Woodward; Robert et al., filed Nov. 1, 2024.
[cited by applicant]
Co-pending U.S. Appl. No. 18/936,845, inventors Woodward; Robert et al., filed Nov. 4, 2024.
[cited by applicant]
European Patent Office Technical Board of Appeal decision T 1514/21 (Monitoring immunosuppressive therapies in a transplant recipient/CAREDX) Dec. 9, 2023 (Year: 2023).
[cited by applicant]
Forshew, Tim. et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Science Translational Medicine 4(136):136ra68, 1-12 (2012).
[cited by applicant]
Forshew, Tim. et al. Supplemental Information: Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Science Translational Medicine 4(136):136ra68, 1-20 (2012).
[cited by applicant]
Garcia Moreira, Vanessa. et al. Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clinical Chemistry 55(11):1958-1966 (2009).
[cited by applicant]
Grinyo, Josep. et al. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transplant International 21(9):879-891 (2008).
[cited by applicant]
Invivioscribe, Instructions for Use Amplification Control. General Purpose Reagent :1-13 (2020).
[cited by applicant]
Ro, Han et al. Association of polymorphisms of interleukin-8, CXCR1, CXCR2, and selectin with allograft outcomes in kidney transplantation. Transplantation 91(1):57-64 (2011).
[cited by applicant]
Scherer, Andreas. Clinical and ethical considerations of massively parallel sequencing in transplantation science. World Journal of Transplantation 3(4):62-67 (2013).
[cited by applicant]
Sigdel, Tara K. et al. A rapid noninvasive assay for the detection of renal transplant injury. Transplantation 96(1):97-101 (2013).
[cited by applicant]
Technology Spotlight: Illumina Sequencing Technology. Illumina :1-4 (2009).
[cited by applicant]
Using a PhiX Control for HiSeq Sequencing Runs. Illumina Technical Note: Sequencing :1-2 (2013).
[cited by applicant]
Yu, Stephanie CY. et al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clinical Chemistry 59(8):1228-1237 (2013).
[cited by applicant]
Zhong, Xiao Yan. et al. Cell-free DNA in urine: a marker for kidney graft rejection, but not for prenaStal diagnosis?. Annals of the New York Academy of Sciences 945(1):250-257 (2001).
[cited by applicant]
Jiang, Peiyong, et al. FetalQuant: deducing fractional fetal DNA concentration from massively parallel sequencing of DNA in maternal plasma. Bioinformatics, 2012, vol. 28, No. 22, pp. 2883-2890.
[cited by applicant]
Qiagen, QIAquick PCR Purification Kit Protocol, Jul. 2008, p. 19-20 (2008).
[cited by applicant]
Cited By (1)